The downregulation of SNORA12 and SNORD97 in tissues from patients with cervical squamous cell carcinoma [37] implies that their secretion from cancer cells may help to evade host immunity against tumors through suppression of both systemic lymphopenia and lymphocyte activity in the TME. The gene discussed is SNORA12; the disease is cervical squamous cell carcinoma.